Amicus Therapeutics Inc

Financials

Flujo de caja de las actividades operativas -233.29 M-202.49 M-166.57 M-69.09 M-33.89 M33.15 M 33.15 M Flujo de caja de las actividades de inversión -13.58 M78.76 M92.32 M98.06 M-560 K-46.43 M -46.43 M Flujo de caja de las actividades financieras 262.86 M212.07 M-7.46 M61.68 M5.12 M610 K 610 K Flujo de caja libre -236.52 M-206.38 M-170.34 M-76.53 M-37.44 M29.85 M 29.85 M

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

FOLD

Financials

Amicus Therapeutics Inc

Noticias

Las acciones de Amicus Therapeutics alcanzan un máximo de 52 semanas en 14,46 dólares

Las acciones de Amicus Therapeutics alcanzan un máximo de 52 semanas en 14,44 dólares

Why Is Adma Biologics (ADMA) Down 45.4% Since Last Earnings Report?

Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?

Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?

Las acciones de Amicus Therapeutics alcanzan un máximo de 52 semanas en 14,39 dólares

Las acciones de Amicus Therapeutics alcanzan un máximo de 52 semanas

Acción de Amicus Therapeutics alcanza un máximo de 52 semanas en $14.38

Amicus Therapeutics stock hits 52-week high at 14.38 USD

Viking Therapeutics Stock Gets RS Rating Upgrade